Adc Therapeutics SA

Filed a patent for "glycoconjugates" on Thu, November 23, 2023

Filed a patent for "glycoconjugates" on Thu, February 8, 2024

Filed a patent for "dosage regimes for the administration of an anti-cd19 adc" on Thu, September 8, 2022

Filed a patent for "pyrrolobenzodiazepine-antibody conjugates" on Thu, February 23, 2023

Filed a patent for "dosage regimes" on Thu, February 9, 2023

Filed a patent for "dosage regime" on Thu, April 6, 2023